Robert A. Branch
#141,021
Most Influential Person Now
Robert A. Branch's AcademicInfluence.com Rankings
Robert A. Branchbiology Degrees
Biology
#10002
World Rank
#13279
Historical Rank
Genetics
#1042
World Rank
#1140
Historical Rank
Download Badge
Biology
Why Is Robert A. Branch Influential?
(Suggest an Edit or Addition)Robert A. Branch's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations (1985) (490)
- Clinical implications of prostaglandin and thromboxane A2 formation (2). (1988) (399)
- Genetic polymorphism of S-mephenytoin hydroxylation. (1989) (317)
- Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review. (2002) (262)
- Prostacyclin production during pregnancy: comparison of production during normal pregnancy and pregnancy complicated by hypertension. (1982) (233)
- Liver disease selectively modulates cytochrome P450–mediated metabolism (2006) (204)
- Determinants of serum antipyrine half-lives in patients with liver disease (1973) (197)
- Effects of age and cigarette smoking on propranolol disposition (1979) (190)
- Propranolol's metabolism is determined by both mephenytoin and debrisoquin hydroxylase activities (1989) (188)
- Clinical implications of prostaglandin and thromboxane A2 formation (1). (1988) (188)
- Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma (2010) (186)
- Prevention of amphotericin B-induced renal impairment. A review on the use of sodium supplementation. (1988) (177)
- Normal metabolism of morphine in cirrhosis. (1981) (171)
- Biological determinants of propranolol disposition in man (1978) (166)
- Genetic predisposition to bladder cancer: ability to hydroxylate debrisoquine and mephenytoin as risk factors. (1987) (166)
- Effect of age and parenchymal liver disease on the disposition and elimination of chlordiazepoxide (librium). (1978) (159)
- Amphotericin B nephrotoxicity in humans decreased by salt repletion. (1983) (155)
- Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction. (2000) (154)
- Prostaglandins and renin release: II. Assessment of renin secretion following infusion of PGI2,E2 and D2 into the renal artery of anesthetized dogs. (1978) (153)
- Clinical outcomes of intravenous immune globulin in severe clostridium difficile-associated diarrhea. (2007) (152)
- Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow. (1974) (140)
- Radiographic emphysema predicts low bone mineral density in a tobacco-exposed cohort. (2011) (140)
- Amphotericin B Nephrotoxicity (1990) (131)
- Intravenous administration of diazepam in patients with chronic liver disease. (1976) (131)
- Intact hepatocyte theory of impaired drug metabolism in experimental cirrhosis in the rat. (1979) (125)
- The clearance of antipyrine and indocyanine green in normal subjects and in patients with chronic liver disease (1976) (120)
- Drugs as Indicators of Hepatic Function (2007) (118)
- Elemental Mercury Vapour Toxicity, Treatment, and Prognosis After Acute, Intensive Exposure in Chloralkali Plant Workers. Part I: History, Neuropsychological Findings and Chelator effects (1992) (114)
- The reduction of lidocaine clearance by dl-propranolol: an example of hemodynamic drug interaction. (1973) (112)
- Effect of salt supplementation on amphotericin B nephrotoxicity. (1991) (111)
- Estrogen and tamoxifen metabolites protect smooth muscle cell membrane phospholipids against peroxidation and inhibit cell growth. (1999) (105)
- Propranolol Disposition in Chronic Liver Disease: A Physiological Approach (1976) (105)
- Phenotypic differences in mephenytoin pharmacokinetics in normal subjects. (1985) (99)
- The participation of prostaglandins in the control of renin release. (1979) (95)
- The Influence of Cirrhosis on Steady-State Blood Concentrations of Unbound Propranolol after Oral Administration (1978) (92)
- Brain uptake of benzodiazepines: effects of lipophilicity and plasma protein binding. (1988) (91)
- Genetically determined polymorphisms in drug oxidation (1986) (91)
- Human liver microsomal N-hydroxylation of dapsone by cytochrome P-4503A4. (1992) (90)
- A study of factors influencing drug disposition in chronic liver disease, using the model drug (+)-propranolol. (1976) (90)
- The influence of sodium status and furosemide on canine acute amphotericin B nephrotoxicity. (1980) (84)
- The relationship between liver volume, antipyrine clearance and indocyanine green clearance before and after phenobarbitone administration in man. (1976) (81)
- Determinants of response to frusemide in normal subjects. (1977) (81)
- Stereoselective metabolism of mephenytoin in man. (1981) (79)
- Pharmacokinetic profile of ABELCET (amphotericin B lipid complex injection): combined experience from phase I and phase II studies (1997) (77)
- Mephenytoin hydroxylation deficiency: Kinetics after repeated doses (1984) (72)
- Characterization and inhibition of mephenytoin 4-hydroxylase activity in human liver microsomes. (1987) (70)
- The contribution of N‐hydroxylation and acetylation to dapsone pharmacokinetics in normal subjects (1990) (69)
- Chloroquine modulation of specific metabolizing enzymes activities: investigation with selective five drug cocktail. (1998) (68)
- The influence of indomethacin on the pharmacokinetics, diuretic response and hemodynamics of furosemide in the dog. (1978) (66)
- Direct enantiomeric resolution of mephenytoin and its N-demethylated metabolite in plasma and blood using chiral capillary gas chromatography. (1984) (62)
- Subacute neurotoxicity following long-term exposure to carbaryl. (1986) (61)
- The differential localization of various drug metabolizing systems within the rat liver lobule as determined by the hepatotoxins allyl alcohol, carbon tetrachloride and bromobenzene. (1981) (60)
- A phase II trial of all-trans-retinoic acid in hormone-refractory prostate cancer: a clinical trial with detailed pharmacokinetic analysis (1997) (60)
- Stereoselective metabolism and disposition of the enantiomers of mephenytoin during chronic oral administration of the racemic drug in man. (1982) (57)
- Extrahepatic glucuronidation of morphine in the dog. (1986) (56)
- The Influence of Radiographic Phenotype and Smoking Status on Peripheral Blood Biomarker Patterns in Chronic Obstructive Pulmonary Disease (2009) (55)
- Development of dapsone toxicity in patients with inflammatory dermatoses: Activity of acetylation and hydroxylation of dapsone as risk factors (1999) (55)
- Low Dose Intrarenal Infusions of PGE2, PGI2/ and 6‐Keto‐PGEx Vasodilate the in Vivo Rat Kidney (1982) (54)
- Effect of PGI2, PGE2 and 6-keto PGF1α on canine gastric blood flow and acid secretion (1978) (52)
- Inverse association of plasma IL-13 and inflammatory chemokines with lung function impairment in stable COPD: a cross-sectional cohort study (2007) (52)
- Furosemide kinetics and dynamics in patients with cirrhosis (1986) (51)
- Scleroderma is associated with differences in individual routes of drug metabolism: A study with dapsone, debrisoquin, and mephenytoin (1990) (51)
- Effectiveness of antipsychotic therapy in a naturalistic setting: a comparison between risperidone, perphenazine, and haloperidol. (1999) (50)
- Effect of chronic disulfiram administration on the activities of CYP1A2, CYP2C19, CYP2D6, CYP2E1, and N-acetyltransferase in healthy human subjects. (2002) (49)
- Liver volume measurements and three-dimensional display from MR images. (1988) (48)
- The effect of PGI2 on canine renal function and hemodynamics. (1978) (48)
- Minimal in vivo activation of CYP2C9-mediated flurbiprofen metabolism by dapsone. (2001) (48)
- Prevalence and Risk of Thrombocytopenia with Valproic Acid: Experience at a Psychiatric Teaching Hospital (2001) (46)
- Further Observations on Relationships between Antipyrine Half-life, Clearance and Volume of Distribution: An Appraisal of Alternative Kinetic Parameters Used to Assess the Elimination of Antipyrine (1980) (45)
- The relationship between pulmonary emphysema and kidney function in smokers. (2012) (45)
- Acute renal artery constriction increases renal prostaglandin I2 biosynthesis and renin release in the conscious dog. (1982) (44)
- Duloxetine pharmacokinetics in cirrhotics compared with healthy subjects. (2005) (42)
- S‐mephenytoin 4‐hydroxylase is inherited as an autosomal‐recessive trait in Japanese families (1987) (42)
- Effect of aminophylline on amphotericin B nephrotoxicity in the dog. (1983) (42)
- Cytochrome P-450 activity is differentially altered in severely injured patients (2005) (41)
- The disposition of propranolol. 8. General implications of the effects of liver blood flow on elimination from the perfused rat liver. (1973) (41)
- A Pharmacokinetic Study of Amphotericin B Lipid Complex Injection (Abelcet) in Patients with Definite or Probable Systemic Fungal Infections (2000) (41)
- The disposition of dapsone in cirrhosis (1992) (41)
- A comparison of the pulmonary, renal and hepatic extractions of PGI2 and PGE2 - PGI2 a potential circulating hormone. (1978) (40)
- Effects of an oral contraceptive on hepatic size and antipyrine metabolism in premenopausal women (1978) (40)
- Influence of hypertonic saline on canine renal blood flow and renin release. (1979) (40)
- Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a large case cohort study (2010) (40)
- Meperidine disposition in man: Influence of urinary pH and route of administration (1981) (40)
- Furosemide disposition in cirrhosis (1982) (40)
- Incidence of Uraemia and Requirements for Maintenance Haemodialysis (1971) (39)
- Antipyrine clearance per unit volume liver: an assessment of hepatic function in chronic liver disease. (1979) (39)
- Mechanisms of amphotericin B-induced reduction of the glomerular filtration rate: a micropuncture study. (1990) (39)
- Renal and systemic hemodynamics in experimental cirrhosis in rats: Relation to hepatic function (1990) (38)
- Indomethacin Decreases Arterial Blood Pressure and Plasma Renin Activity in Rats with Aortic Ligation (1981) (38)
- Impaired drug metabolism in experimental cirrhosis in the rat. (1978) (38)
- Genetically determined drug‐metabolizing activity and desipramine‐associated cardiotoxicity: A case report (1993) (37)
- The disposition of propranolol. VII. The effects of saturable hepatic tissue uptake on drug clearance by the perfused rat liver. (1973) (37)
- 6-Keto-prostaglandin E1 is more potent than prostaglandin I2 as a renal vasodilator and renin secretagogue. (1981) (37)
- Drug Metabolites in Renal Failure (1981) (37)
- A UPLC-MS/MS assay of the "Pittsburgh cocktail": six CYP probe-drug/metabolites from human plasma and urine using stable isotope dilution. (2011) (36)
- Stereoselective metabolism and pharmacogenetic control of 5-phenyl-5-ethylhydantoin (nirvanol) in humans. (1984) (36)
- Sodium status influences chronic amphotericin B nephrotoxicity in rats (1989) (36)
- Potassium depletion potentiates amphotericin-B-induced toxicity to renal tubules. (1995) (35)
- Genetic polymorphisms in the DNA repair genes XPD and XRCC1, p53 gene mutations and bladder cancer risk. (2010) (34)
- Gender-based outcomes differences in unresectable hepatocellular carcinoma (2008) (34)
- A clinical and experimental study of platelet function in chronic renal failure (1972) (34)
- The urinary sodium: potassium ratio and response to diuretics in resistant oedema. (1977) (34)
- The onset of sodium retention in experimental cirrhosis in rat is related to a critical threshold of liver function (1990) (34)
- CYP2D6 mRNA expression in circulating peripheral blood mononuclear cells correlates with in vivo debrisoquine hydroxylase activity in extensive metabolizers. (1996) (34)
- Designing a Strategy to Promote Safe, Innovative Off-Label Use of Medications (2006) (33)
- Effects of age on meperidine disposition (1985) (33)
- Clonal analysis of human recurrent superficial bladder cancer by immunohistochemistry of P53 and retinoblastoma proteins. (1996) (31)
- Hemodynamic effects of adenosine in conscious hypertensive and normotensive rats. (1986) (31)
- Chronic caffeine administration exacerbates renovascular, but not genetic, hypertension in rats. (1986) (29)
- Preservation of glucuronidation in carbon tetrachloride-induced acute liver injury in the rat. (1981) (29)
- A pharmacodynamic interaction between caffeine and phenylpropanolamine (1991) (28)
- Disposition of furosemide in functionally hepatectomized dogs. (1981) (27)
- Correlation of polymorphic expression of CYP2D6 mRNA in bladder mucosa and tumor tissue to in vivo debrisoquine hydroxylase activity. (1994) (27)
- Increase in hepatic blood flow and d-propranolol clearance by glucagon in the monkey. (1973) (27)
- All-trans-retinoic acid modulation of drug-metabolizing enzyme activities: investigation with selective metabolic drug probes (1997) (27)
- Adenosine in Renin‐Dependent Renovascular Hypertension (1988) (27)
- Drug metabolites in renal failure: pharmacokinetic and clinical implications. (1981) (26)
- Evaluation of flurbiprofen urinary ratios as in vivo indices for CYP2C9 activity. (2007) (26)
- Pharmacogenetic association between the formation of 4-hydroxymephenytoin and a new metabolite of S-mephenytoin in man. (1987) (25)
- SODIUM DEPLETION ENHANCES NEPHROTOXICITY OF AMPHOTERICIN B (1981) (24)
- Attenuation of cisplatinum-induced nephrotoxicity in the rat by high salt diet, furosemide and acetazolamide (1985) (24)
- Stereoselectivity of the Arene Epoxide Pathway of Mephenytoin Hydroxylation in Man (1984) (24)
- Effect of phenobarbitone on plasma lipids in normal subjects. (1976) (23)
- The disposition and effects of sedatives and analgesics in liver disease. (1978) (23)
- Mechanisms of amphotericin B-induced decrease in glomerular filtration rate in rats (1991) (23)
- Caffeine potentiates the renin response to diazoxide in man. Evidence for a regulatory role of endogenous adenosine. (1989) (23)
- Interaction between angiotensin II and adenosine in mediating the vasoconstrictor response to intrarenal hypertonic saline infusions in the dog. (1990) (23)
- Effect of aminophylline on renal vasoconstriction produced by amphotericin B in the rat (1983) (22)
- Significance of increased serum GGTP levels in HCC patients. (2010) (22)
- Amphotericin B protects cis-parinaric acid against peroxyl radical-induced oxidation: amphotericin B as an antioxidant (1997) (22)
- Improved high-performance liquid chromatographic determination of debrisoquine and 4-hydroxydebrisoquine in human urine following direct injection. (1996) (22)
- The procarcinogen hypothesis for bladder cancer: activities of individual drug metabolizing enzymes as risk factors. (1995) (21)
- Analysis of hydroxylated and demethylated metabolites of mephenytoin in man and laboratory animals using gas-liquid chromatography and high-performance liquid chromatography. (1982) (21)
- Phenobarbital influences the development of sodium retention in liver disease induced by bile duct ligation in the rat (1990) (21)
- Elemental Mercury Vapour Toxicity, Treatment, and Prognosis After Acute, Intensive Exposure in Chloralkali Plant Workers. Part II: Hyperchloraemia and Genitourinary Symptoms (1992) (21)
- Is carbaryl as safe as its reputation? Does it have a potential for causing chronic neurotoxicity in humans? (1986) (21)
- The influence of clinical study design on cost-effectiveness projections for the treatment of gram-negative sepsis with human anti-endotoxin antibody. (1995) (21)
- Low activity of dapsone N-hydroxylation as a susceptibility risk factor in aggressive bladder cancer. (1994) (20)
- Clinical evaluation of fibre-optic sigmoidoscopy employing the Olympus CF-SB colonoscope (1971) (20)
- Prostaglandin biosynthesis does not participate in hypercapnia-induced cerebral vasodilatation in the dog. (1983) (20)
- Hemodynamic drug interactions: the reduction of oxyphenbutazone clearance by dl-propranol in the dog. (1973) (19)
- The influence of liver diseases on drug disposition. (1979) (19)
- Furosemide and bumetanide: A study of responses in normal English and German subjects (1976) (19)
- Cimetidine-carbaryl interaction in humans: evidence for an active metabolite of carbaryl. (1992) (19)
- Quantitative determination of carbaryl and carbaryl metabolites by reversed-phase high-performance liquid chromatography. (1987) (19)
- Lack of Tacrolimus-Induced Cardiomyopathy (2001) (19)
- Amphotericin-b nephrotoxicity in humans decreased by sodium supplements with coadministration of ticarcillin or intravenous saline (1987) (18)
- The ability to 4-hydroxylate debrisoquine is related to recurrence of bladder cancer. (1992) (18)
- Biological determinants of propranolol disposition in normal subjects and patients with cirrhosis [proceedings]. (1977) (17)
- Digitoxin-quinidine interaction: potentiation during administration of cimetidine. (1981) (17)
- The cytochrome P450 suicide inhibitor, 1-aminobenzotriazole, sensitizes rats to zymosan-induced toxicity. (1998) (17)
- Mephenytoin disposition and serum bile acids as indices of hepatic function in chronic viral hepatitis (1997) (17)
- Clearance by the liver: current concepts in understanding the hepatic disposition of drugs. (1983) (17)
- Enzyme induction and beta-adrenergic receptor blocking drugs. (1984) (17)
- A sensitive method for the simultaneous determination of caffeine and its dimethylxanthine metabolites in human plasma : Application to CYP1A2 phenotyping (1998) (17)
- Drug metabolism in hepatosplenic schistosomiasis in the Sudan: a study with antipyrine. (1978) (17)
- Network-based analysis of survival for unresectable hepatocellular carcinoma. (2010) (16)
- Risperidone use in a teaching hospital during its first year after market approval: economic and clinical implications. (1995) (16)
- Practical approach to grading evidence for formulary recommendations. (2005) (16)
- Role of sodium in the protective effect of ticarcillin on gentamicin nephrotoxicity in rats (1989) (16)
- Hepatic and extrahepatic glucuronidation of lorazepam in the dog (1981) (16)
- Indomethacin is a placental vasodilator in the dog. The effect of prostaglandin inhibition. (1978) (15)
- Association of low CYP3A activity with p53 mutation and CYP2D6 activity with Rb mutation in human bladder cancer. (1996) (15)
- Amphotericin B as an intracellular antioxidant: protection against 2,2'-azobis(2,4-dimethylvaleronitrile)-induced peroxidation of membrane phospholipids in rat aortic smooth muscle cells. (1997) (15)
- Effects of indomethacin on beta adrenoreceptor-stimulated renin release in the dog. (1982) (15)
- Assessment of the extent to exogenous prostaglandin I2 is converted to 6-keto-prostaglandin E1 in human subjects. (1982) (15)
- Changing physician prescribing behavior: the community-acquired pneumonia intervention trial. (2000) (15)
- Comparison of the pulmonary, hepatic and renal extraction of PGI2 and 6-keto-PGE1. (1982) (15)
- United States Medical Practice Summary (2006) (14)
- Effect of amphotericin B on intracellular calcium levels in cultured glomerular mesangial cells. (1992) (14)
- Monoacetyldapsone inhibition of dapsone N-hydroxylation by human and rat liver microsomes. (1994) (13)
- Integrated regional haemodialysis and renal transplantation centre. (1970) (13)
- Adenosine inhibits beta-adrenoceptor but not DBcAMP-induced renin release. (1987) (13)
- Pharmacokinetics and pharmacodynamics of ethanol, whiskey, and ethanol with n‐propyl, n‐butyl, and iso‐amyl alcohols (1977) (13)
- Role of sodium in protection by extended-spectrum penicillins against tobramycin-induced nephrotoxicity (1990) (13)
- Sensitive high-performance liquid chromatographic determination of chlorzoxazone and 6-hydroxychlorzoxazone in plasma. (1993) (13)
- Aminophylline inhibits renal vasoconstriction produced by intrarenal hypertonic saline. (1983) (13)
- Sodium retention and hepatic function after two‐thirds hepatectomy in the rat (1991) (12)
- Attenuation of noradrenergic neurotransmission by the thromboxane synthetase inhibitor, UK 38,485. (1984) (12)
- A Re-evaluation of Intersubject Variation in Enzyme Induction in Man (1979) (12)
- SYSTEMIC PROSTAGLANDIN I2 SYNTHESIS IS NORMAL IN PATIENTS WITH BARTTER'S SYNDROME (1983) (12)
- Carbaryl metabolism is inhibited by cimetidine in the isolated perfused rat liver and in man. (1988) (11)
- Chronic Caffeine Administration Exacerbates Renovascular, but not Genetic, Hypertension in Rats (1987) (11)
- Endogenous prostacyclin synthesis is decreased during activation of the renin-angiotensin system in man. (1984) (11)
- Effect of an adenosine receptor antagonist on acute amphotericin B nephrotoxicity. (1990) (11)
- Effects of atrial natriuretic factor on hormone-induced renin release. (1987) (11)
- Effect of cyclooxygenase and thromboxane synthase inhibition on the response to angiotensin II in the hypoperfused canine kidney. (1987) (11)
- HCC in Older Patients (2010) (10)
- The lack of an effect of furosemide on uterine prostaglandin metabolism in vivo. (1978) (10)
- Role of binding in distribution of furosemide: where is nonrenal clearance? (1983) (10)
- Major determinants of drug disposition in chronic liver disease: a study with indocyanine green and antipyrine [proceedings]. (1975) (10)
- Use of a database computer program to identify trends in reporting of adverse drug reactions. (1990) (10)
- Induction of drug-metabolizing enzymes by the enantiomers of normephenytoin in the rat. (1981) (10)
- Monocyte fructose 1,6-bisphosphatase and cytidine deaminase enzyme activities: potential pharmacodynamic measures of calcitriol effects in cancer patients (2006) (10)
- Cholestasis in transplant patients—what is the role of cyclosporin? (1992) (10)
- Comparison of [14C] Phenacetin and Amino[14C]pyrine Breath Tests after Acute and Chronic Liver Injury in the Rat 1 (1980) (9)
- Drug metabolism in rats bearing a pituitary mammotropic tumor. (1979) (9)
- Metabolic interactions of putative cytochrome P4503A substrates with alternative pathways of dapsone metabolism in human liver microsomes. (1996) (9)
- Quantitative aspects of prostacyclin metabolism in humans. (1983) (8)
- Hemodynamic drug interactions. (1974) (8)
- Effect of precursors of the 1, 2, and 3 series prostaglandins on renin release and renal blood flow in the dog. (1981) (8)
- Prolactin, diuretics and urinary electrolytes in normal subjects. (1976) (8)
- Vancomycin entry into lung lymph in sheep (1987) (8)
- Adenosine inhibits renin release induced by suprarenal-aortic constriction and prostacyclin (1989) (8)
- Caffeine potentiates the renin response to furosemide in rats. Evidence for a regulatory role of endogenous adenosine. (1989) (8)
- Prescribing for patients with liver disease. (1989) (7)
- The elimination of ethyl, n-propyl, n-butyl and iso-amyl alcohols by the isolated perfused rat liver. (1976) (7)
- Platelet function in chronic renal failure. (1972) (7)
- HCC in young adults. (2010) (7)
- Periportal localization of lorazepam glucuronidation in the isolated perfused rat liver. (1983) (7)
- Inhibition of renal vasoconstriction induced by intrarenal hypertonic saline by the nonxanthine adenosine antagonist CGS 15943A. (1989) (7)
- Elimination of canrenone in congestive heart failure and chronic liver disease (1977) (7)
- Drug metabolism and liver disease: a drug–gene–environment interaction (2017) (7)
- Participation of prostaglandins in the control of renin release. (1982) (7)
- Plasma uric acid concentration related to the urinary excretion of aldosterone and of electrolytes in normal subjects. (1975) (7)
- Proceedings: The influence of chronic liver disease on the elimination of d-propranolol, anti-pyrine, and indocyanine green. (1974) (6)
- Pharmacokinetic drug interaction with cimetidine. (1986) (5)
- Environmental procarcinogen hypothesis of bladder cancer in humans: Dapsone hydroxylation as a susceptibility risk factor for aggressive bladder cancer. (1997) (5)
- Pharmacokinetic and Pharmacological Aspects of Polymorphic Drug Oxidation in Man (1984) (5)
- Sodium retention and hepatic function following partial portal vein ligation in the rat. (1993) (5)
- Alkalosis and Urate Clearance (1975) (5)
- Regional hemodynamic effects of dopamine in the unanesthetized primate: failure to alter flow-dependent hepatic drug clearance. (1973) (5)
- A comparison of the effect of frusemide and bumetanide on the diuretic response and fibrinolytic mechanism in man. (1976) (5)
- OUTCOMES ASSESSMENT IN ROUTINE PRACTICE : USE OF AN ELECTRONIC MEDICAL RECORDS DATABASE (1999) (5)
- A relationship between plasma uric acid concentration and the apparent response to frusemide in normal subjects. (1975) (4)
- Intrarenal hypertonic saline infusions in dogs with thoracic caval constriction. (1987) (4)
- The effects of indomethacin and hemorrhage on splanchnic blood flow. (1982) (4)
- Nitric oxide does not contribute to sodium retention and peripheral vasodilation induced by partial portal vein ligation in rats. (1995) (4)
- The use of radioactive hippuran in the management of cadaveric renal transplants. (1971) (4)
- THE INFLUENCE OF SODIUM AND POTASSIUM SUPPLEMENTS ON THE DIURETIC RESPONSES TO FRUSEMIDE ADMINISTRATION IN NORMAL SUBJECTS (1978) (4)
- Impaired hepatic elimination of paranitrophenol and its metabolites in the rat following chronic ethanol pretreatment. (1989) (4)
- Methylxanthines augment the renin response to suprarenal-aortic constriction (1989) (4)
- Familial Bartter's syndrome and the effect of indomethacin in one family member. (1982) (4)
- Bladder cancer recurrence and its association with cytochrome P-450IID6 activity. (1992) (4)
- Acute and chronic effects of flucytosine on amphotericin B nephrotoxicity in rats (1992) (4)
- Relationship between oxidative hepatic metabolism, urinary sodium excretion and sympathetic nerve activity in experimental cirrhosis in the rat. (1995) (3)
- Pharmacokinetics of frusemide related to diuretic response [proceedings]. (1976) (3)
- Interaction between thromboxane A2 and angiotensin II in postischemic renal vasoconstriction in dogs. (1993) (3)
- Pharmacokinetics after a single oral dose of bopindolol in patients with cirrhosis (2004) (3)
- Antagonism of endogenous mineralocorticoids in normal subjects by prorenoate potassium and spironolactone (1976) (3)
- Mechanism of amphotericin-B (Ampho-B)-induced reduction of the glomerular filtration rate (GFR): a micropuncture study. (1990) (3)
- 2301 – AGE RELATED EFFECTS OF SMOKING ON ELIMINATION OF PROPRANOLOL (P) ANTIPYRINE (Ap) AND INDOCYANINE GREEN (ICG) (1978) (2)
- Increased blood and urine copper after residential exposure to copper naphthenate. (1992) (2)
- PARACETAMOL TOXICITY AND PROPRANOLOL (1973) (2)
- Good Clinical Practice and Good Laboratory Practice (2009) (2)
- Proceedings: The metabolism of ethyl, n-propyl, n-butyl and iso-amyl alcohols by the isolated perfused rat liver. (1975) (2)
- Influence of the adenosine receptor antagonist, CGS 15943A, on renal function after reconstruction of chronic renal artery stenosis in the dog. (1992) (2)
- A Variant In The Promoter Of MUC5B Is Associated With Idiopathic Pulmonary Fibrosis And Not Chronic Obstructive Pulmonary Disease (2011) (2)
- [Prevention of nephrotoxicity of amphotericin B during the treatment of deep candidiasis]. (1987) (1)
- Proceedings: The relationships between liver volume and the disposition of antipyrine and indocyanine green before and after phenobarbitone treatment. (1975) (1)
- Proceedings: Prolactin, frusemide and renal function in normal men. (1975) (1)
- The metabolism of ethyl, n-propyl, n-butyl and iso-amyl alcohols by the isolated perfused rat liver. (1975) (1)
- Selective Modulation of Cyp‐Mediated Metabolism in Liver Disease (2003) (1)
- Association Of Plasma Levels Of MMP And TIMP With Clinical Phenotypes Of Chronic Obstructive Pulmonary Disease (2011) (1)
- THERELATIONSHIP BETWEENLIVERVOLUME, ANTIPYRINECLEARANCEAND INDOCYANINE GREENCLEARANCEBEFOREAND AFTERPHENOBARBITONEADMINISTRATION INMAN (1976) (1)
- Radiographic Emphysema Independently Predicts Low Bone Mineral Density In Chronic Obstructive Pulmonary Disease (2010) (1)
- Effects of thromboxane synthase inhibitors on renal function (1988) (1)
- Fibre-optic colonoscopy: a critical assessment. (1971) (1)
- Association of low CYP 3 A activity with p 53 mutation and CYP 2 D 6 activity with Rb mutation in human bladder cancer (2005) (1)
- Unilaterally nephrectomized rat with aortic ligation: a uremic model of severe hypertension. (1985) (1)
- Hospital Junior Staff (1966) (1)
- Proceedings: The influence of glucagon on regional blood flow in the rhesus monkey. (1973) (1)
- Renal thromboxane A2 release stimulated by angiotensin II in the hypoperfused canine kidney. (1987) (1)
- Systemic synthesis of prostaglandin I2 following sustained infusion of angiotensin II in conscious dogs. (1986) (1)
- Pharmacokinetics of chlorzoxazone An in vivo probe of cytochrome P4502E1 activity (1993) (1)
- DETERMINANTSOFRESPONSE TO FRUSEMIDEINNORMALSUBJECTS (1977) (0)
- Hepatic enzyme induction postpones the onset of sodium retention in experimental cirrhosis in rats induced by bile duct excision (1989) (0)
- DRUG METABOLISM IN OLDER OLTx PATIENTS: EFFECTS OF DONOR AND RECIPIENT AGE. (1999) (0)
- The effect of indomethacin (I) on placental (P) and myometrial (M) blood flow (1977) (0)
- Contributors (2022) (0)
- Clinicopharmacologic perspective of duodenal ulcer therapy. (1978) (0)
- PII‐37 (2006) (0)
- Cefotetan (Cefotan): a new cephalosporin. (1986) (0)
- Chapter 15 – Good Clinical Practice and Good Laboratory Practice (2017) (0)
- Pharmacokinetics offrusemide related todiuretic response (1976) (0)
- Drug metabolism in liver disease (2016) (0)
- Cytochrome P450IIIA-mediated hydroxylation of dapsone in normal subjects and cirrhotics (1990) (0)
- Preclinical Pharmacodynamics of Antihypertensives (1993) (0)
- Serum gammaglutamyl transpeptidase, alkaline phosphatase, and alfa-fetoprotein in small HCCs. (2011) (0)
- Drug metabolism and liver disease (2007) (0)
- AcuteandChronic Effects ofFlucytosine on Amphotericin B Nephrotoxicity inRats (1992) (0)
- 2114 – HYPERTONIC SALINE DECREASES RENAL BLOOD FLOW AND RENIN SECRETION “IN VIVO” (1978) (0)
- Clinical evaluation offibreoptic sigmoidoscopy employing theOlympus CF-SBcolonoscope (1971) (0)
- Original Article The Influence of Cirrhosis on Steady-State Blood Concentrations of Unbound Propranolol after Oral Administration' (1978) (0)
- Physiologic Changes In Tobacco Exposed Individuals With Visually Absent Emphysema But Increases In Low Attenuation Units By Quantitative CT (2010) (0)
- The pharmacogenetics of bladder cancer Hydroxylation pathways and cytochrome P450 activity (1993) (0)
- Recurrence of bladder cancer is associated with cytocjrome P450llD6 debrisoquine 4-hydroxylase activity (1991) (0)
- Catecholamines and sodium retention in experimental cirrhosis in the rat. Relation to hepatic function (1990) (0)
- Effect of Phenobarbitone on Plasma Lipids, Lipoproteins and Enzyme Induction in Healthy Young Subjects (1976) (0)
- DNA repair genes XPD and XRCC1 polymorphisms, p53 gene mutations and bladder cancer risk (2006) (0)
- 2897 – THE INFLUENCE OF CIRRHOSIS ON FREE PROPRANOLOL CONCENTRATION DURING CHRONIC ORAL ADMINISTRATION (1978) (0)
- Abstract 2010: A Network Phenotyping Strategy (NPS) for HCC identifies distinct coherent survival groupings from observed clinical traits (2010) (0)
- Changes in CYP450 enzyme activity over time following liver transplantation (2005) (0)
- The effect of liver disease on drugs (1997) (0)
- A clinical andexperimental study ofplatelet function inchronic renal failure (1972) (0)
- Topics in Clinical Pharmacology: Introduction (1988) (0)
- Ribavirin (virazole): a novel antiviral agent against viral respiratory tract infections. (1986) (0)
- Distinct Association Of CCP And SPD With Clinical Phenotypes Of Chronic Obstructive Pulmonary Disease (2010) (0)
- Predictors Of Bone Mineral Density Loss In Chronic Obstructive Pulmonary Disease (2012) (0)
- Letter: Prolactin and uric acid in man. (1975) (0)
- Adenosine Inhibits Norepinephrine but not Dibutyryl Cyclic AMP-Induced Renin Release (1986) (0)
- Systemic PGI2 Synthesis in Man is Decreased during Activation of the Renin-Angiotensin System (1983) (0)
- 2,3-Dimercaptosuccinic acid (DMSA) versus N-acetyl-penicillamine (NAP) for the treatment of elemental mercury toxicity (1990) (0)
- MP-19.13: CYP3A mediated dapsone recovery ratio may predict tumour progression in superficial bladder cancer (2007) (0)
- Genetic Susceptibility to Risk for Bladder Cancer in Individuals Working in High Risk Occupations (2005) (0)
- Letter: Alkalosis and urate clearance. (1975) (0)
- [Correlation of renin-angiotensin system and prostanoid system in renal circulation. I. Measurement of glomerular filtration rate and renin secretion rate]. (1984) (0)
- Tacrolimus-induced cardiomyopathy: a systematic review of over 3600 adult patients (1998) (0)
- Letter: Paracetamol toxicity and propranolol. (1973) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Robert A. Branch?
Robert A. Branch is affiliated with the following schools:
